ProQR Therapeutics N.V.
PRQR | NASDAQ
$1.88
+$0.02 (+1.08%)
Sep 22, 2026, 12:35 PM ET · Market open
Market Data
Market Cap $195.87M
Enterprise Value $67.6M
Beta 0.03
Average Volume 942.8K
Shares Outstanding (Diluted) 109.96M
Shares Change YoY 4.38%
Institutional Ownership 33.30%
Exchange NASDAQ
ISIN NL0010872495
Price Performance
Price Change 1M -20.9%
Price Change 3M -1.6%
Price Change 6M 17.7%
Price Change YTD -6.5%
Price Change 1Y -13.9%
Price Change 3Y 26.5%
Price Change 5Y -76.1%
1M CAGR (ann.) -1.1%
1Y CAGR (ann.) -15.1%
5Y CAGR (ann.) -26.0%
All-Time CAGR -15.8%
Valuation
PE Ratio -3.99
Forward PE N/A
PEG Ratio -0.71
Forward PEG -0.25
PS Ratio 9.04
Forward PS 8.70
PB Ratio 2.16
P/FCF Ratio -3.34
P/Adj. FCF Ratio -3.11
P/OCF Ratio -3.54
EV/Sales 3.64
EV/EBIT -1.67
EV/EBITDA -1.79
EV/FCF -1.34
Earnings Yield -24.6%
FCF Yield -29.4%
Adj. FCF Yield -31.6%
Financial Health
Net Cash €112.58M
Total Debt €13.19M
Cash & Short-Term Investments €117.08M
Total Assets €133.5M
Current Ratio 3.49
Quick Ratio 3.49
Debt / Equity Ratio 0.17
Debt / EBITDA -0.35
Debt / FCF -0.26
OCF / Debt -3.73
Interest Coverage 0.00
Altman Z-Score -3.29
Piotroski F-Score 1
Margins & Profitability
Gross Profit Margin 92.3%
Operating Profit Margin -232.7%
EBITDA Margin -202.9%
Net Profit Margin -228.3%
FCF Margin -270.8%
Adj. FCF Margin -291.1%
SBC / Revenue 20.3%
SBC Impact (per share) -7.5%
Returns
Return on Assets -31.8%
Return on Equity -68.4%
Return on Invested Capital -41.9%
Return on Capital Employed -43.8%
Return on Tangible Assets -31.8%
Historical Growth (CAGR)
Revenue CAGR 3Y 66.3%
Revenue CAGR 5Y 95.3%
Revenue CAGR 10Y 7.0%
EPS CAGR 3Y -17.7%
EPS CAGR 5Y 23.0%
EPS CAGR 10Y 16.4%
FCF CAGR 3Y -16.4%
FCF CAGR 5Y -18.6%
FCF CAGR 10Y -0.6%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 12
EPS Growth Next 3Y 1.7%
Revenue Growth Next 3Y 49.3%
Earnings Date Nov 4, 2026
EPS Estimate (next Q) -$0.13
EPS Growth Est (next Q) -8.3%
Revenue Est (next Q) $4.98M
Revenue Growth Est (next Q) 27.4%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $3
Price Target Upside 61.3%
Cash Flow
Operating Cash Flow €-49.14M
Free Cash Flow €-50.29M
Adj. Free Cash Flow €-54.07M
FCF Per Share -$0.46
OCF Per Share -$0.45
OCF/S Ratio -264.6%
Income Statement
Revenue €18.57M
Gross Profit €17.15M
Operating Income €-43.22M
EBITDA €-37.69M
Net Income €-42.4M
EPS (Diluted) -$0.40
Revenue / Employee $111.89K
Profit / Employee $-255.43K
Employees 166
Add to Watchlist
Select watchlists to add or remove PRQR